KEGG results showed that SYTZD might exert multi-anti-NAFLD effects by activating the thyroid hormone, insulin resistance, HIF-1, mTOR, and AMPK pathways. This evidence concerns the gene HIF1A and metabolic dysfunction-associated steatotic liver disease.